1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Connecticut >
  6. Kemin Industries Acquires Bactana

M&A Deal Summary

Kemin Industries Acquires Bactana

On May 12, 2025, Kemin Industries acquired life science company Bactana

Acquisition Highlights
  • This is Kemin Industries’ 5th transaction in the Life Science sector.
  • This is Kemin Industries’ 6th transaction in the United States.
  • This is Kemin Industries’ 1st transaction in Connecticut.

M&A Deal Summary
Date 2025-05-12
Target Bactana
Sector Life Science
Buyer(s) Kemin Industries
Deal Type Add-on Acquisition

Target

Bactana

Farmington, Connecticut, United States
Bactana is a research-driven company specializing in advancements in intestinal health and fermentation technology. The company has patented the use of a select group of microbes that manipulate the microbial ecology of animals to enhance the interaction of the microbiome, immune system, and metabolism (immunometabolism). It creates therapies for pets to treat metabolic conditions and digestive disorders, while also developing sustainable products for use in livestock production that reduce natural resource utilization, greenhouse gas emissions, and antibiotic usage. Bactana is based in Farmington, Connecticut.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Kemin Industries

Des Moines, Iowa, United States
Category Company
Sector Life Science
Employees2,000
DESCRIPTION

Kemin Industries, Inc. is a global nutritional ingredient company that uses science to create solutions and products. The company provides over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. Kemin has more than 2,000 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

DEAL STATS #
Overall 8 of 9
Sector: Life Science M&A 5 of 5
Type: Add-on Acquisition M&A Deals 6 of 7
State: Connecticut M&A 1 of 1
Country: United States M&A 6 of 7
Year: 2025 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-25 Archangel

United States

Archangel develops antimicrobial solutions for the biofuel production industry. The company provides antibiotic-free antimicrobials and preservatives tailored specifically for fermentative biofuel production processes.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-08-27 Hennessy Research Associates

Lenexa, Kansas, United States

Hennessy Research Associates specializes in the Research & Development and manufacturing of vaccines for infectious diseases of animals. The company develops biological manufacturing processes, in vitro test development, lab animal and host animal challenge model development, and USDA ELISA Reference Requalification methods. Hennessy Research Associates was founded in 2000 and is based in Lenexa, Kansas.

Buy -
Mergr

Solution for

Product

Company

Legal